-
Something wrong with this record ?
Multimarker screening of oxidative stress in aging
K. Syslová, A. Böhmová, M. Mikoška, M. Kuzma, D. Pelclová, P. Kačer,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
NT13299
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Free Medical Journals
from 2008
PubMed Central
from 2008
Europe PubMed Central
from 2008
ProQuest Central
from 2014-01-01
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2009-01-01
Medline Complete (EBSCOhost)
from 2011-01-01
Health & Medicine (ProQuest)
from 2014-01-01
Wiley-Blackwell Open Access Titles
from 2008
PubMed
25147595
DOI
10.1155/2014/562860
Knihovny.cz E-resources
- MeSH
- Biomarkers metabolism MeSH
- Dinoprost analogs & derivatives metabolism MeSH
- Guanosine analogs & derivatives metabolism MeSH
- Humans MeSH
- Oxidative Stress * MeSH
- DNA Damage MeSH
- Proteins chemistry metabolism MeSH
- Aging * MeSH
- Tyrosine analogs & derivatives metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Aging is a complex process of organism decline in physiological functions. There is no clear theory explaining this phenomenon, but the most accepted one is the oxidative stress theory of aging. Biomarkers of oxidative stress, substances, which are formed during oxidative damage of phospholipids, proteins, and nucleic acids, are present in body fluids of diseased people as well as the healthy ones (in a physiological concentration). 8-iso prostaglandin F2α is the most prominent biomarker of phospholipid oxidative damage, o-tyrosine, 3-chlorotyrosine, and 3-nitrotyrosine are biomarkers of protein oxidative damage, and 8-hydroxy-2(')-deoxyguanosine and 8-hydroxyguanosine are biomarkers of oxidative damage of nucleic acids. It is thought that the concentration of biomarkers increases as the age of people increases. However, the concentration of biomarkers in body fluids is very low and, therefore, it is necessary to use a sensitive analytical method. A combination of HPLC and MS was chosen to determine biomarker concentration in three groups of healthy people of a different age (twenty, forty, and sixty years) in order to find a difference among the groups.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014092
- 003
- CZ-PrNML
- 005
- 20190827093902.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2014/562860 $2 doi
- 035 __
- $a (PubMed)25147595
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Syslová, Kamila $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic. $7 xx0145898
- 245 10
- $a Multimarker screening of oxidative stress in aging / $c K. Syslová, A. Böhmová, M. Mikoška, M. Kuzma, D. Pelclová, P. Kačer,
- 520 9_
- $a Aging is a complex process of organism decline in physiological functions. There is no clear theory explaining this phenomenon, but the most accepted one is the oxidative stress theory of aging. Biomarkers of oxidative stress, substances, which are formed during oxidative damage of phospholipids, proteins, and nucleic acids, are present in body fluids of diseased people as well as the healthy ones (in a physiological concentration). 8-iso prostaglandin F2α is the most prominent biomarker of phospholipid oxidative damage, o-tyrosine, 3-chlorotyrosine, and 3-nitrotyrosine are biomarkers of protein oxidative damage, and 8-hydroxy-2(')-deoxyguanosine and 8-hydroxyguanosine are biomarkers of oxidative damage of nucleic acids. It is thought that the concentration of biomarkers increases as the age of people increases. However, the concentration of biomarkers in body fluids is very low and, therefore, it is necessary to use a sensitive analytical method. A combination of HPLC and MS was chosen to determine biomarker concentration in three groups of healthy people of a different age (twenty, forty, and sixty years) in order to find a difference among the groups.
- 650 12
- $a stárnutí $7 D000375
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a dinoprost $x analogy a deriváty $x metabolismus $7 D015237
- 650 _2
- $a guanosin $x analogy a deriváty $x metabolismus $7 D006151
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a oxidační stres $7 D018384
- 650 _2
- $a proteiny $x chemie $x metabolismus $7 D011506
- 650 _2
- $a tyrosin $x analogy a deriváty $x metabolismus $7 D014443
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Böhmová, Adéla $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Mikoška, Miloš $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Kuzma, Marek, $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic. $d 1974- $7 xx0075964
- 700 1_
- $a Pelclová, Daniela $u Department of Occupational Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Na Bojisti 1, 120 00 Prague 2, Czech Republic.
- 700 1_
- $a Kačer, Petr, $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic. $d 1969- $7 xx0081992
- 773 0_
- $w MED00180520 $t Oxidative medicine and cellular longevity $x 1942-0994 $g Roč. 2014, č. - (2014), s. 562860
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25147595 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20190827094122 $b ABA008
- 999 __
- $a ok $b bmc $g 1071673 $s 896970
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 2014 $c - $d 562860 $i 1942-0994 $m Oxidative medicine and cellular longevity $n Oxid Med Cell Longev $x MED00180520
- GRA __
- $a NT13299 $p MZ0
- LZP __
- $a Pubmed-20150420